Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Immunomodulatory and Anti-oxidative Effect of the Direct TRPV1 Receptor Agonist Capsaicin on Schwann Cells
Neuromuscular and Clinical Neurophysiology (EMG)
P15 - Poster Session 15 (12:00 PM-1:00 PM)
1-001
In the present study, we describe an anti-inflammatory and anti-oxidative influence of capsaicin on Schwann cells (SCs) in an in vitro setting. 
The active component of chili pepper, capsaicin, is the direct agonist of the transient receptor potential channel vanilloid subfamily member-1. The effect of nutritive factors on chronic inflammatory demyelinating polyneuropathy (CIDP), a chronic inflammatory disease of the peripheral nervous system has not been described before.  Its anti-inflammatory effect in the animal model experimental autoimmune neuritis (EAN) has been previously demonstrated from our group. 

We analyzed the effect of capsaicin on Schwann cells’ gene expression pattern, major histocompatibility complex class II (MHC-II) expression, and H2O2 induced oxidative stress. Furthermore, the effect of capsaicin on myelination was examined in a SC-dorsal root ganglia (DRG)-coculture by myelin basic protein staining. Finally, in order to investigate the isolated effect of capsaicin on SCs in EAN pathology, we transplant naïve and capsaicin pre-treated SCs intrathecally in EAN immunized rats and analyzed clinical presentation, electrophysiological parameters, and cytokine expression in the sciatic nerve.

In SC culture, incubation with capsaicin significantly reduces interferon gamma induced MHC-II production as well as toll-like receptor 4 and intercellular adhesion molecule 1 mRNA expression. Calcitonin gene-related peptide mRNA production is significantly up-regulated after capsaicin treatment. Capsaicin reduced H2O2 induced oxidative stress in SC in a preventive, but not therapeutic setting. In a SC-DRG-coculture, capsaicin does not affect myelination rate. After intrathecally transplantation of naïve and capsaicin pre-treated SCs in EAN immunized rats, naïve, but not capsaicin pre-treated intrathecally SCs ameliorated EAN pathology in rats. 

We demonstrate an immunomodulatory and anti-oxidative effect of capsaicin in a SC culture. These results are in concordance with previous data showing an anti-inflammatory effect of capsaicin, which might be highly relevant for CIDP patients.
Authors/Disclosures
Kalliopi Pitarokoili, MD (St Josefs Hospital)
PRESENTER
Dr. Pitarokoili has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring.
No disclosure on file
Jeremias Motte, MD (UK RUB- St. Josef-Hospital) The institution of Prof. Motte has received research support from Ruhr-Univerity Bochum.
Melissa Sgodzai Melissa Sgodzai has nothing to disclose.
No disclosure on file
Rafael M. Klimas (St. Josef Hospital - Ruhr-University Bochum) Mr. Klimas has nothing to disclose.
Bjorn Ambrosius No disclosure on file
Ralf Gold, MD (Neurologische Universitaetsklinik) Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Gisa Ellrichmann No disclosure on file
No disclosure on file